Anson Funds Management LP Atossa Therapeutics, Inc. Transaction History
Anson Funds Management LP
- $420 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding ATOS
# of Institutions
88Shares Held
27.8MCall Options Held
63.6KPut Options Held
53.2K-
Black Rock Inc. New York, NY9.2MShares$7.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.59MShares$5.66 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.85MShares$2.45 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.86MShares$1.6 Million0.0% of portfolio
-
State Street Corp Boston, MA1.73MShares$1.49 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $109M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...